miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2.

He Y, Yang Y, Liao Y, Xu J, Liu L, Li C, Xiong X

Open source

DOI
10.1016/j.omto.2020.03.009
Published
2020 Jun 26
Container
Molecular therapy oncolytics
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omto.2020.03.009,
  title = {miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2.},
  author = {He Y and Yang Y and Liao Y and Xu J and Liu L and Li C and Xiong X},
  year = {2020},
  journal = {Molecular therapy oncolytics},
  doi = {10.1016/j.omto.2020.03.009},
  url = {https://doi.org/10.1016/j.omto.2020.03.009}
}

RIS

TY  - JOUR
TI  - miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2.
AU  - He Y
AU  - Yang Y
AU  - Liao Y
AU  - Xu J
AU  - Liu L
AU  - Li C
AU  - Xiong X
PY  - 2020
JO  - Molecular therapy oncolytics
DO  - 10.1016/j.omto.2020.03.009
UR  - https://doi.org/10.1016/j.omto.2020.03.009
ER  -

APA

Y, H., Y, Y., Y, L., J, X., L, L., C, L., & X, X. (2020). miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2.. Molecular therapy oncolytics. https://doi.org/10.1016/j.omto.2020.03.009

Source records